tirzepatide compound no longer available FDA ban on compounded tirzepatide: Switch to name brand medications Compounded Tirzepatide – $179/month –

This was the first demonstration that a GLP-1R agonist produces cardiovascular benefit independent of glycaemic effects, expanding the research interest in GLP-1R agonism beyond metabolic and weight endpoints

It is licensed for type 2 diabetes and chronic weight management, with blood pressure reduction being a secondary benefit that complements its primary metabolic effects

Proposed perfusion/neurotransmitter mechanisms in a GLP-1 agonist sexual dysfunction case report may contribute to genital arousal pain or discomfort patterns in some patients, but generalisability is unknown

1,3-Propanediol

Remarkable works have partially explored the wide range of possibilities offered by these nanotechnological approaches to provide early and non-invasive diagnostic tools, as well as potential targeted therapeutic strategies against several neurological diseases, moving from bench to bedside (Kumar et al., 2020)